Analytical Data
-
基因名
BTNL2
- Application
-
别名
Butyrophilin-like protein 2; BTNL2; BTL-II
-
种属
Human
-
表达系统
E. coli
-
标签
N-Avi;N-His
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
NP_062548.1
-
表达区间
L24-W455
-
分子量
55-57 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
BTNL2 (Butyrophilin-like 2) is a member of the butyrophilin family, which plays a crucial role in immune regulation and T cell activation. Recent studies have highlighted BTNL2's involvement in various autoimmune diseases and its potential as a therapeutic target. It is expressed in various immune cells and can modulate the response of T cells, influencing the balance between pro-inflammatory and anti-inflammatory signals. The understanding of BTNL2's structure-function relationship is essential for developing recombinant proteins that can be used in research and therapeutic applications. Recombinant BTNL2 proteins can serve as important tools for elucidating the mechanisms of T cell regulation and the role of BTNL2 in immune responses. Moreover, they may offer insights into its potential as a biomarker for certain diseases, making BTNL2 a promising candidate for future immunological studies and drug development. The investigation of BTNL2 recombinant proteins not only enhances our comprehension of immune modulation but also opens avenues for innovative treatment strategies in autoimmune disorders, cancer, and other immune-related conditions.
